Skip to main content
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota 10 - July 2020
  3. Gut microbiota
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota 10 - July 2020
  3. Gut microbiota
Gastroenterology

Gut microbiota

Parkinson's disease

By Pr. Markku Voutilainen
Turku University Faculty of Medicine; Turku University Hospital, Department of Gastroenterology, Turku, Finland

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

 Hay bacillus. Computer illustration of Bacillus subtilis bacteria.

About this article

Created 24 August 2021
Updated 04 November 2021

Bacillus subtilis and Parkinson's disease 

Goya ME, Xue F, Sampedro-Torres-Quevedo C, et al. Probiotic Bacillus subtilis protects against α-synuclein aggregation in C. Elegans. Cell Rep. 2020.

To better understand the impact of gut microbiota on the progression / severity of Parkinson’s disease (PD) and on α-synuclein (α-syn) aggregates in Lewy bodies, the authors used a nematode Caenorhabditis elegans model. They noted that both spores and vegetative cells of a Bacillus subtilis strain induced a biofilm formation in the worm gut and the release of bacterial metabolites. Thus, protective pathways such as sphingolipid metabolism were differentially regulated; preformed α-syn aggregates removal and α-syn aggregation inhibition were observed in young and old animals. From authors’ point of view, the effects of this strain as a food supplement should be considered in PD treatment.

The impact of antibiotics on cancer immunotherapy 

Iglesias-Santamaria A. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer. Clin Transl Oncol 2020.

Gut microbiota may influence the efficacy and toxicity of anticancer therapy. According to present results, it significantly impacts the response to an Immune Checkpoint Inhibitors (ICI) treatment. The study evaluated the impact of antibiotics, proton pump inhibitors (PPI), steroids, and opioids use on the therapeutic response to ICI treatment defined by iRECIST1 criteria. It showed that antibiotic use per se was not associated with any reduced efficacy of ICI treatment, but multiple or prolonged antibiotic courses impaired the outcome of immune therapy. This is the first study showing that concomitant use of opioids, but not PPIs or steroids, is associated with poorer outcomes of ICI therapy.

Tags
Gastroenterology Neurology Oncology Cancer

en_view en_sources

    Focus
    Microbiota 10 - July 2020
    • Overview
      • Gut microbiota and Clostridioides difficile
    • Commented articles
      • The Mediterranean diet alters the gut microbiota in the elderly, reduces frailty and improves health: study NU-AGE
      • Metagenomics of the faecal virome: cumulative effect of the quantity of gluten and enteroviruses risk of coeliac disease autoimmunity in predisposed children – the TEDDY study
    • Congress review
      • Gut Microbiota For Health World Summit 2020
    • Press review
      • Vaginal microbiota #10
      • Skin microbiota
      • Gut microbiota
    Created 24 August 2021
    Updated 04 November 2021

    About this article

    To know more about this topic.

    Main topic

    Parkinson's disease

    Content type

    Press review
    Skin microbiota
    Focus

    Microbiota 10 - July 2020

    Overview

    Gut microbiota and Clostridioides difficile

    Commented articles

    The Mediterranean diet alters the gut microbiota in the elderly, reduces frailty and improves health: study NU-AGE Metagenomics of the faecal virome: cumulative effect of the quantity of gluten and enteroviruses risk of coeliac disease autoimmunity in predisposed children – the TEDDY study

    Congress review

    Gut Microbiota For Health World Summit 2020

    Press review

    Vaginal microbiota #10 Skin microbiota Gut microbiota
    Gastroenterology
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article

    The blue poop challenge: a reliable method to evaluate gut transit?

    By Pr. Gianluca Ianiro Gastroenterology Department, Fondazione Policlinico Universitario Agostino Gemelli- ...

    Find out more

    New perspectives in autism: the role of microbiota in social communication

    Overview By Dr. Vincent Trebossen Child and Adolescent P...

    Find out more

    Gut microbiota #15

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department of Ga...

    Find out more

    Microbiome topics at gastro 2021

    Congress Review By Pr. Eamonn M M Quigley Lynda K and David M Underwood Center for Digestive Disorders, Di...

    Find out more

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more

    Microbiota in covid-19 pandemic

    Overview By Pr. Conceição Calhau NOVA Medical School, New University of Lisbon, Portugal By Pr. Pedro Povo...

    Find out more
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    en_redirection

    en_you_are_about_to_leave

    • en_be_redirected
    • en_stay_on_biocodex

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    04.05.2022

    Miscarriage: Is vaginal dysbiosis a suspect?

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo